In addition to the adverse consequences of elevated VEGF-A levels in pancreatic cancer, abundant expression of HIF-1α contributes substantially to the pathophysiology of this disease [57, 58]. This evidence concerns the gene VEGFA and familial pancreatic carcinoma.